ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981

Publisher Receives Six Figures Settlement In Copyright Case

May 11, 1990

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

DRCA Board Split On Use Of Cancer Control Funds By Centers; NCAB Probably Will Decide The Issue

November 26, 1982

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976